Evoke Pharma Inc
F:EV0
Evoke Pharma Inc
F:EV0
Precio:
0,2036
EUR
-9,99%
Capitalización de mercado:
€680,6 mil
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
M
|
Matador Resources Co
F:7MR
|
US |
|
D
|
Deutsche Lufthansa AG
XMUN:LHA
|
DE |
|
N
|
Nokia Oyj
BMV:NOKN
|
FI |
|
Marfrig Global Foods SA
F:MGP1
|
BR |
|
Deutsche Lufthansa AG
F:LHA
|
DE |
|
Biotalys NV
F:86C
|
BE |
|
T
|
Terumo Corp
XMUN:TUO
|
JP |
|
B
|
Burberry Group PLC
F:BB2
|
UK |
|
Biotalys NV
XBRU:BTLS
|
BE |
|
S
|
Skechers USA Inc
F:SKAA
|
US |
|
Safehold Inc
F:J0W
|
US |
|
Onex Corp
TSX:ONEX
|
CA |
|
L
|
Liberty Broadband Corp
NASDAQ:LBRDK
|
US |
|
A
|
Avance Gas Holding Ltd
F:A07
|
BM |
|
EROAD Ltd
NZX:ERD
|
NZ |
|
E
|
Eurazeo SE
XBER:EUQ
|
FR |
|
Cathay Financial Holding Co Ltd
LSE:CFHS
|
TW |
|
A
|
Aeroports de Paris SA
XMUN:W7L
|
FR |
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
JD Sports Fashion PLC
F:9JD
|
UK |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
S
|
SBI Holdings Inc
XMUN:ZOF
|
JP |
|
Pennant International Group PLC
LSE:PEN
|
UK |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
